Quarterly Revenue Growth
Revenue growth in Q3 2024 was 3% compared to the previous year, with notable performance in Healthcare and Education segments.
Record Sales Quarter
Achieved a record high in quarterly bookings company-wide, indicating strong sales conversion across all segments.
Commercial Segment Rebound
The Commercial segment achieved 12% sequential growth over Q2 2024, with digital offerings seeing a 9% sequential increase.
Margin Improvement
Adjusted EBITDA margins increased by 140 basis points, and adjusted EPS increased by 21% over the prior year quarter.
Positive Outlook for 2025
Sales pipeline remains robust into Q4, laying the foundation for continued growth in 2025.
Debt Reduction and Share Repurchase
Net debt decreased by $69.4 million compared to Q2 2024, and $7.3 million used for share repurchases.